[Anti-HIV chemotherapy targeted at host-cellular factors].
Baba
M
M
Division of Human Retroviruses, Faculty of Medicine, Kagoshima University.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000975:Antioxidants; D016207:Cytokines / Q000378:metabolism; D003864:Depression, Chemical; D004353:Drug Evaluation, Preclinical; D016322:HIV Enhancer; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism; D015398:Signal Transduction; D014775:Virus Activation / Q000187:drug effects
D019380:Anti-HIV Agents; D000975:Antioxidants; D016207:Cytokines; D016328:NF-kappa B